VC  Delphi Ventures

http://www.delphiventures.com/





     Office Locations:

160 Bovet Rd., Suite #408
San Mateo, CA 94402
Phone: 650-854-9650

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded 1988, Delphi Ventures has over $ $1.1 billion in committed capital and is focused on early stage healthcare investing, including medical devices and biotechnology. Over 160 Delphi-backed companies have raised more than $3.5 billion in capital and more than 120 of the firm's companies have either completed an initial public offering or have been acquired by leading healthcare corporations. Delphi typically invests between $500K and $12.0M in companies with sales values between $350 million and $400 million.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Deepa R. Pakianathan PhD Managing Partner
    Doug Roeder Managing Partner
    Matthew T. Potter Chief Financial Officer and Partner
    Olivia Liao Controller

     

    Portfolio companies include:


      Aegea Medical
        web link


      Alder BioPharmaceuticals
        web link


      Anulex Technologies
        web link


      Astute Medical
        web link


      BaroSense
        web link


      Breathe Technologies
        web link


      Calithera Biosciences
        web link


      EBR Systems
        web link


      Elenza
        web link


      ForSight Vision5
        web link


      InnerPulse
        web link


      Ivantis
        web link


      Karyopharm Therapeutics
        web link


      Labcyte
        web link


      Lutonix
        web link


      NeuroMetrix
        web link


      NeuroVista
        web link


      OncoMed Pharmaceuticals
        web link


      PhotoThera
        web link


      Pivot Medical
        web link


      PixelOptics
        web link


      PolyRemedy
        web link


      Relypsa
        web link


      Revance Therapeutics
        web link


      Senseonics
        web link


      SequentMedical
        web link


      Soteira
        web link


      Sotera Wireless
        web link


      SynergEyes
        web link


      Tandem Diabetes Care
        web link


      TriVascular
        web link


      Vibrynt
        web link


      Vital Therapies
        web link


      VytronUS
        web link


     

    Recent News: